Flint, S.W. orcid.org/0000-0003-4878-3019 (2024) Rethinking the label anti-obesity medication. The Lancet Diabetes & Endocrinology, 12 (5). pp. 301-302. ISSN 2213-8587
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2024 Elsevier Ltd. This is an author produced version of an article published in The Lancet Diabetes & Endocrinology. Uploaded in accordance with the publisher's self-archiving policy. |
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Psychology (Leeds) |
Depositing User: | Symplectic Publications |
Date Deposited: | 21 Mar 2024 10:48 |
Last Modified: | 23 Oct 2024 00:13 |
Status: | Published |
Publisher: | Elsevier |
Identification Number: | 10.1016/S2213-8587(24)00071-8 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:210582 |